FORA Capital, LLC - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 396 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.3%.

Quarter-by-quarter ownership
FORA Capital, LLC ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$1,144,742
-34.0%
9,996
-25.3%
0.16%
-41.8%
Q4 2022$1,733,262
+66.3%
13,376
+41.9%
0.28%
+40.0%
Q3 2022$1,042,000
+117.5%
9,428
+47.7%
0.20%
+110.5%
Q2 2022$479,000
+59.1%
6,385
+91.2%
0.10%
-18.8%
Q4 2021$301,000
-99.9%
3,339
-54.7%
0.12%
+9.3%
Q2 2021$573,000,000
-18.5%
7,373
-21.8%
0.11%
-53.7%
Q1 2021$703,000,000
-31.0%
9,427
+57.8%
0.23%
+49.0%
Q4 2020$1,019,000,000
-43.1%
5,974
-46.6%
0.16%
-74.7%
Q2 2020$1,792,000,000
+43.2%
11,177
+15.3%
0.61%
+386.5%
Q4 2019$1,251,000,0009,6980.13%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Sonic Fund II, L.P. 112,689$14,541,00014.93%
Casdin Capital, LLC 670,000$86,457,0007.95%
Logos Global Management LP 226,002$29,163,0007.19%
Avoro Capital Advisors LLC 1,760,000$227,110,0006.67%
Camber Capital Management LP 600,000$77,424,0003.94%
STANSBERRY ASSET MANAGEMENT, LLC 71,133$9,179,0003.74%
Eventide Asset Management 996,000$128,524,0003.62%
CADIAN CAPITAL MANAGEMENT, LP 550,000$70,972,0003.14%
RTW INVESTMENTS, LP 605,762$78,168,0002.95%
Consonance Capital Management LP 356,145$45,957,0002.80%
View complete list of SAREPTA THERAPEUTICS INC shareholders